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Abstract 
 
Background: Is the increasing prevalence of autistic disorder (AD) a well-documented trend or merely a reflection of the 
wider recognition of AD among both the public at large and health care professionals? Data from relevant studies are 
frequently compromised by comparisons of different sites and different diagnostic methods. 
Objectives: To explore changes over time, we reviewed the following: 1) the frequency of AD diagnoses; 2) the characteristics 
of the diagnosed children; and 3) the ages of the children when initial concerns were addressed and AD diagnoses made. 
Method: We compared the case records of children between the ages of 1 and 17 years who were residing in Nordland 
County, Norway, and who were diagnosed with AD during two different data collection periods: 1992 (Cohort 1) and 2009 
(Cohort 2).  
Results: In Cohort 1, 28 children were diagnosed with AD; 71 children in Cohort 2 received AD diagnoses. The increase was 
greatest among children with intelligence quotient (IQ) values of at least 70. The proportion of children with genetic 
syndromes was around 20% in both cohorts. Median age at AD diagnosis did not differ between the two cohorts (4.5 vs. 5.0 
years, respectively). When the two cohorts were combined, children with IQ values of 70 or more without a genetic syndrome 
and those with IQ values of less than 50 with genetic syndromes were diagnosed at approximately the same age (5.5 and 5.3 
years, respectively). Both groups were significantly older at diagnosis as compared with children with IQ values of less than 
50 without genetic syndromes (3.5 years).  
Conclusions: The increase in the number of children diagnosed with AD is consistent with findings from international 
studies. Contrary to predictions, the age at diagnosis was not reduced over time. A higher proportion of children with IQ 
values in the average range in the latter cohort may have contributed to this. A delayed diagnosis of AD among children with 
genetic syndromes may indicate that early autism symptoms are attributed to the genetic condition. Clinical implications are 
discussed. 
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Introduction 
Prevalence estimates for autistic disorder (AD) (core 
autism) have varied widely over time, from around 
4.7 per 10,000 in studies published between 1966 and 
1993 (1) to around 74 per 10,000 in more recent 
epidemiological studies (2). For the whole autism 
spectrum, current prevalence estimates exceed 1%. A 
                                                     
† E. Grindheim has sadly passed away before this paper was finished. 
 
recent report from the U.S. Centers for Disease 
Control and Prevention reported that 1 in 68 children 
received ASD diagnoses (3), although the study 
methods used in that report have been criticized (4). 
It is clear that autism is not the very rare condition 
that it was once considered to be. It is likely that 
factors such as the broadening of the concept to 
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autism spectrum disorder (ASD) (5), the expansion 
of the diagnostic criteria, the development of 
services, and the improved awareness of the 
condition have played major roles in the rise in 
prevalence estimates (6). 
Among the many variables that potentially 
contributed to changes in prevalence estimates is the 
recognition that autism can be associated with a 
range of specific genetic syndromes. However, 
estimates of comorbidity also vary widely. For 
example, ASD has been reported in 21% to 50% of 
boys with fragile X syndrome and in 24% to 60% of 
individuals with tuberous sclerosis (7). Comorbidity 
figures for autism among patients with Cornelia de 
Lange syndrome range from 32% to 62% (8). Among 
children with Down syndrome, AD was reported in 
6%, and ASD was reported in 18% (9); similar figures 
8% and 19% respectively, were reported by Moss and 
colleagues (10). Warner and colleagues (11) reported 
that the proportion of children with Down syndrome 
who met the cutoff for autism on the Social 
Communication Questionnaire (12) was 16.5%.  
Earlier diagnosis is another factor that affects 
prevalence estimates (13). AD can reliably be 
diagnosed by experienced clinicians in children 3 
years old or younger (14). However, the average age 
at AD diagnosis varies across studies from 3.1 years 
(15) to 4.8 years (16) to 5.2 years (17) in accordance 
with sample characteristics and ascertainment 
methods (18,19). Parents are initially concerned 
about social development, but they also have worries 
about general delays and other specific problems 
(20,21). In addition, many of them have to wait a long 
time for diagnostic confirmation (22,23).  
Geographical factors are also considered 
important. For example, although recent U.S. figures 
have suggested rates of more than 1% for ASD (3) 
and a South Korean study reported prevalence 
estimates of 0.9% for AD and 2.6% for ASD (24), an 
epidemiological study in Norway (25) found rates of 
only 0.14% for AD and 0.5% for ASD. 
Some researchers argue that increased prevalence 
rates are influenced by “diagnostic substitution”: in 
recent years, children with intellectual disability, 
attention-deficit/hyperactivity disorder, or language 
disorder have been more likely to be diagnosed with 
AD or ASD in addition to these other conditions 
rather than intellectual disability, attention-
deficit/hyperactivity disorder, or language disorder 
alone (6,26,27). Overshadowing has also been 
described in relation to coexisting attention-
deficit/hyperactivity disorder and ASD, which 
suggests that an initial ADHD diagnosis may be 
associated with a delayed ASD diagnosis (28). The 
increased frequency of the occurrence of ASD with 
other medical, developmental, and behavioral 
disorders increases the possibility of “over-
shadowing” in that all additional problems are 
attributed to the medical condition (7,28,29). 
Finally, terminology and diagnostic criteria have 
also changed over time. In the past, the term autistic 
disorder was used to describe children who met criteria 
for core autism according to the criteria presented in 
the Diagnostic and Statistical Manual of Mental Disorders, 
Fourth Edition (DSM-IV) (30) or the International 
Statistical Classification of Diseases and Related Health 
Problems, 10th Revision (ICD-10) (31). However, with 
the recent changes of the DSM-5 classification (5), 
the term autism spectrum disorder is now used to include 
all children who previously would have been 
diagnosed as having either AD, Asperger syndrome, 
atypical autism, or pervasive developmental disorder 
– not otherwise specified. 
Because of the variability in the estimates in 
different countries and over time, Fombonne (6) has 
argued that repeated studies using the same 
methodology and conducted in the same 
geographical area at different points in time are 
important to obtain more reliable information about 
time trends. Two studies from Nordland County in 
Norway were used in the present study to address 
this issue by comparing two groups of children 
diagnosed with AD and residing in the county at the 
times of data collection. The data were collected 17 
years apart using records from the central hospital 
responsible for the diagnostic assessment and follow-
up of all children with AD in the county. 
The main focus of the current study was to 
examine the change in the proportion of children 
between the ages of 1 and 17 years who had been 
diagnosed with AD (ICD-10: F84.0/DSM-IV-TR: 
299.0) and who were living in Nordland County, 
Norway, during two separate data collection periods: 
1992 and 2009. We also examined differences in child 
characteristics over time, including intelligence 
quotient (IQ) values and the presence of genetic 
syndromes. The referral procedures in Nordland 
County for children who were suspected of having 
AD were the same for both years studied, and the 
children were diagnosed and registered at the same 
specialized services in the county during both time 
periods. Health services in Norway are free of charge 
for all children, and children are routinely offered 
developmental check-ups at well-baby clinics 
throughout the first 4 years of life. 
The aims of the study were to determine the 
following: 1) the change in the proportion of children 
living in Nordland County and registered with an AD 
diagnosis at the time of the two data collections; 2) 
the changes in child characteristics with respect to 
developmental level and genetic conditions; 3) the 
changes over time in the age at which parents first 
became concerned about their child’s development 
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and the child’s age at diagnostic confirmation; and 4) 
the associations between the child’s characteristics 
and the ages of first concerns and diagnosis. 
In the light of previous studies that have 
investigated changes in the rates of AD diagnosis, it 
was predicted that there would be a significantly 
greater number of children diagnosed with AD in 
2009 as compared with 1992. It was also expected 
that there would be more children with normal range 
intellectual ability and AD in the 2009 data collection 
and that the proportion of children with both genetic 
syndromes and AD would increase. The age of 
parental first concern and age of diagnosis were 
expected to be lower in the data collected in 2009 as 
compared with 1992 as a result of a greater focus on 
early identification (32,33). The presence of a genetic 
syndrome was expected to reduce both the age of 
first concern and the age at AD diagnosis, although 
children with IQ values in the normal to high range 
were predicted to be older when parents reported 
their first concern as well as when the diagnosis 
occurred. 
 
Method 
Participants 
In 1992, a retrospective record-based study was 
conducted including all children between 1 and 17 
years old who had been diagnosed with AD and who 
were living in Nordland County at the time of the 
data collection (34); this group will hereafter be 
referred to as Cohort 1. Case records from the hospital 
were used to retrieve information related to birth, 
medical conditions, and diagnostic procedures. A 
replication of the study that used the same method 
to retrieve information was carried out in 2009 to 
result in two non-overlapping cohorts; the group 
identified in that study will hereafter be called Cohort 
2. In both studies, all children had been assessed and 
diagnosed by the hospital’s Autism Team in 
collaboration with the Paediatric Ward. Cohort 1 
comprised 28 children born between January 1, 1975, 
and December 31, 1991; Cohort 2 comprised 71 
children born between January 1, 1992, and 
December 31, 2008.  
All children included in the two data collections 
lived in rural areas or small towns and attended 
mainstream kindergarten or schools. The majority of 
the children (92%) were ethnic Norwegians. During 
the time period that covered the birth years of the 
children in both cohorts, there was a decrease in the 
general population with regard to the number of 
children between the ages of 1 and 17 years from 
approximately 65,610 in 1975 to 56,808 in 1992 to 
53,686 in 2009. The method of only using hospital 
records to identify children with AD does not allow 
for the calculation of true prevalence; however, since 
the catchment area, children’s ages, and method of 
referral were the same, estimates of the proportion 
of AD diagnoses among the referred children across 
time can be compared. 
 
Ethics 
The study was registered by the Medical Director at 
the Central Hospital of Nordland as a quality 
assurance study and approved by the Ombudsman 
for Data Protection and the Northern Regional 
Ethical Committee. 
 
Diagnostic assessments 
For Cohort 1, diagnoses were made by a specialized 
autism team that included a psychologist and a 
pediatrician on the basis of diagnostic criteria 
presented in the DSM-III-R (35). For Cohort 2, 
specialists from the autism team diagnosed the 
children in accordance with ICD-10 criteria (31), 
which are comparable to the criteria for AD in the 
DSM-IV. All children were also observed at home 
and at kindergarten/school. The Autism Diagnostic 
Observation Schedule (36) was routinely used for 
children who were diagnosed after 2007 and for 
some who had been diagnosed earlier (n = 14). 
Genetic syndromes were diagnosed by genetic 
experts at the university hospitals in Tromsø and 
Oslo with the use of the best available screening 
techniques at the time. In Cohort 1, 22 children 
(79%) were assessed with either chromosomal 
analysis (n = 19) or computed tomography/magnetic 
resonance scanning (n = 3). Comparable numbers 
for Cohort 2 revealed the presence of 55 such 
children (77%): 52 who were diagnosed with 
chromosomal analysis and three who were diagnosed 
with computed tomography/magnetic resonance 
scanning. 
 
Cognitive assessments 
In Cohort 1, almost all children (n = 25; 89%) were 
assessed with the Vineland Adaptive Behavior Scales 
(VABS) (37). One child’s cognitive level was assessed 
with the Bayley Scales of Infant Development (38), 
one was obtained via clinical assessment, and data 
were missing for one child. In Cohort 2, all but 2 
children (n = 69; 97%), were formally assessed with 
at least one of the following tests: Bayley Scales, 
Wechsler IQ measures, Leiter-R, or Vineland 
Adaptive Behavior Scales (37). The IQ scores were 
categorized as normal (IQ ≥ 70), mild intellectual 
disability (IQ = 50-69), moderate intellectual 
disability (IQ = 30-49), and severe intellectual 
disability (IQ < 30). 
 
Statistical analysis 
Data analysis was carried out with the use of SPSS 
version 23 (39). Kolmogorov-Smirnov testing for 
skewness and kurtosis (40) indicated that the 
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distribution of data for the age of first concern and 
for the diagnosis of AD deviated significantly from 
the normal curve, so nonparametric analyses (i.e., 
Mann–Whitney U test and Kruskal-Wallis one-way 
analysis of variance) based on median scores were 
used. For each p value, the corresponding z-scores 
are given in the parenthesis. Associations between 
the age of first parental concern and the age of 
diagnosis were calculated using Pearson’s 
correlations (two-tailed). The chi-squared test (X2) 
was used to assess differences in frequency across 
time. When cell frequencies were small, Fisher’s 
exact test was used. The significance level was set at 
p ≤ .05.  
 
 
 
 
 
Results 
Cohort comparisons 
 
TABLE 1. Intellectual levels of children in Cohorts 1 and 2 
 Cohort 1 (1992) 
(N = 27*) 
Cohort 2 (2009) 
(N = 71) 
 
Intellectual level  
 
N (%) 
 
N (%) 
Normal (IQ > 70) 0 (0) 16 (23) 
Mild intellectual disability (IQ 50-69) 3 (11) 13 (18) 
Moderate intellectual disability (IQ 30-49) 3 (11) 22 (31) 
Severe intellectual disability (IQ < 30) 21 (78) 20 (28) 
IQ, Intelligence quotient. 
*Data missing for one individual 
 
 
TABLE 2. Genetic syndromes in Cohorts 1 and 2 
 
 
Cohort I (1992) 
(N = 28) 
Cohort 2 (2009) 
(N = 71) 
 
Genetic syndromes 
 
N (%) 
 
N (%) 
Down 0 3 (4.2%) 
Fragile X 0 1 (1.4%) 
DiGeorge 0 1 (1.4%) 
Williams 0 1 (1.4%) 
Cornelia de Lange 0 2 (2.8%) 
Distal trisomy 15q 0 1 (1.4%) 
Smith-Lemli-Opitz 1 (3.5%) 0 
Tuberous sclerosis 3 (11%) 1 (1.4%) 
Other chromosomal deviations 2 (7%) 2 (2.8%) 
Malformations 0 1 (1.4%) 
Total 6 (21%) 13 (18%) 
 
 
 
 
 
Frequency of autistic disorder diagnoses 
In 1992 (Cohort 1), the total number of children 
between the ages of 1 and 17 years with a diagnosis 
of AD residing in Nordland county was 28 (21 boys 
[75%]), which corresponded to about 0.05%1 of the 
total child population of 56,808. In 2009 (Cohort 2), 
71 children were diagnosed (55 boys [77%]), which 
corresponded to about 0.13% of the total child 
population of 53,686. Thus, the proportion of 
                                                     
1 This is not the population prevalence, but it provides the proportion 
of AD diagnoses among children 1 to 17 years old relative to the child 
children with AD had significantly increased across 
time (X2[1, N = 110,494] = –4.61; p < .001).  
 
Child characteristics: intelligence quotient and the presence of 
genetic syndromes  
Children’s developmental level 
In Cohort 1, the majority of children (89%) had 
moderate or severe intellectual disability (IQ < 50); 
none had intellectual levels in the normal range (IQ 
≥ 70). In Cohort 2, 42 children (59%) had moderate 
population from which they were recruited. This for the comparison of 
Cohort 1 versus Cohort 2. 
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or severe intellectual disability; 16 (23%) had IQ 
scores within the normal range (Table 1). There were 
significantly more children with intellectual levels in 
the normal range in Cohort 2 (Fisher’s exact test; p 
= .04).  
 
Genetic syndromes  
In Cohort 1, 6 children (21%) had diagnosed genetic 
syndromes; in Cohort 2, the corresponding number 
was 13 (18%); there was no significant difference 
(Fisher’s exact test; p = .78). The types of genetic 
syndromes were identified differed across both 
cohorts, with only tuberous sclerosis occurring in 
both (Table 2).  
For two children in Cohort 1, the age at genetic 
syndrome diagnosis was missing. In all other cases, 
the genetic diagnosis was made at an earlier age than 
the diagnosis of AD. All four affected children in 
Cohort 1 and nine of the 16 affected children in 
Cohort 2 received their genetic syndrome diagnoses 
before the age of 12 months.  
 
 
 
 
TABLE 3. Parents’ first concerns about their children’s development 
Main presenting 
problem* 
 
Social impairment 
 
Ritualistic/repetitive 
behaviors 
Delay/loss of 
language 
 
General  
developmental 
delay 
Epilepsy 
Cohort 1 (N = 25) 13 (52%) 0 4 (16%) 7 (28%) 1 (4%) 
Cohort 2 (N = 67) 43 (64.2%) 6 (9%) 8 (11.9%) 9 (13.4%) 1 (1.5%) 
*Data missing for three individuals in Cohort 1 and four individuals in Cohort 2 
 
 
 
 
 
Age and type of parents’ first concerns 
For both cohorts, parental concerns about their 
children’s development were often expressed before 
the age of 12 months (59% in Cohort 1; 39% in 
Cohort 2), and almost all parents reported concerns 
by the time their children reached the age of 3 years 
(93% in Cohort 1; 84% in Cohort 2).2 There was no 
significant difference across cohorts with regard to 
the age in months at first concerns: for Cohort 1, the 
median was 9 months, and for Cohort 2, the median 
was 18 months (z = 1.10; Mann–Whitney U test, p 
= .27).  
Most parents reported more than one type of 
concern. However, in both cohorts, initial worries 
fell into four main categories. Concerns about social 
development (e.g., lack of eye contact, reduced 
interest in social interaction) were most prevalent, 
and these were often noted in combination with 
ritualistic behavior, language delay, or general 
developmental delay. These issues were noted before 
the age of 12 months in eight children (31%) in 
Cohort 1 and in 17 children (24%) in Cohort 2. The 
next most frequent concerns involved general 
developmental delay, and this was followed by a 
delay or loss of language and the presence of 
ritualistic/repetitive behaviors. Seizures as the sole 
                                                     
2 Age data were missing for one child in Cohort 1 and four children 
in Cohort 2. 
 
cause of early concern occurred in only one case in 
each cohort (Table 3). 
 
Age at autistic disorder diagnosis 
There was no significant cohort difference in age in 
months at the time of AD diagnosis: for Cohort 1, 
the median age was 54 months, and it was 60 months 
for Cohort 2 (z = 0.24; Mann–Whitney U test, p 
=.81). The percentage of children who received a 
diagnosis of AD before the age of 36 months was 
similar in the two cohorts: three (11%) in Cohort 1 
versus nine (13%) in Cohort 2 (Fisher’s exact test; p 
= .58). The majority of children—16 (59%) in 
Cohort 1 and 50 (70%) in Cohort 2—were diagnosed 
before the age of 6 years. The same proportion of 
children in both cohorts (18%) was diagnosed at the 
age of 8 years or older.  
The relationship between the age at first concern 
and the age at AD diagnosis was investigated. In 
Cohort 1, the age of first parental concern was 
positively correlated with the age at AD diagnosis 
(r[25] = .41; p = .03): the earlier the concerns were 
noted, the earlier the age at AD diagnosis. In Cohort 
2, there was no significant relationship between initial 
parental concerns and age at AD diagnosis (r[65] = 
–.15; p = .23).  
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Combined cohorts 
Intelligence quotient and genetic syndrome in relation to age of 
first concerns and autism diagnosis 
There were no significant differences between 
cohorts with respect to age of first concerns and AD 
diagnosis. The two cohorts were thus combined to 
increase the sample size to explore the association 
between the presence of genetic syndromes or 
intellectual disability and the age of first concern and 
AD diagnosis. 
Table 4 summarizes the ages of first concerns and 
AD diagnosis according to intellectual and genetic 
status. The children were divided into four mutually 
exclusive groups: 1) IQ < 50 with genetic syndromes; 
2) IQ < 50 without genetic syndromes; 3) IQ = 50 to 
69 without genetic syndromes; and 3) IQ ≥ 70 
without genetic syndromes. As predicted, children 
with IQ values in the normal range (≥70) were 
significantly older than children with IQ values of 50 
or less (irrespective of genetic syndrome) when they 
were first suspected of showing atypical development 
(comparison with genetic syndrome: z = 3.00; 
Mann–Whitney U test, p < .001; with no genetic 
syndrome: z = 2.50; Mann–Whitney U test, p < .015). 
As predicted, the age at which parents first became 
concerned was significantly earlier for children with 
genetic syndromes. These children—all of whom 
had IQ values of less than 50—were diagnosed with 
AD significantly later than children at the same 
intellectual level without genetic syndromes (z = 
2.21; Mann–Whitney U test, p = .027).  
 
 
TABLE 4. Age of first parental concerns and age of autism diagnosis in relation to intellectual level and the presence of genetic 
syndromes for Cohorts 1 and 2 (N = 94) 
 Age of concern in months Age of diagnosis in years 
Subgroups* Median Range Median Range 
IQ > 70 (N = 16) 24.0 4.0-36.0 5.5 3.0-15.0 
IQ = 50-69 (N = 15) 18.0 5.0-48.0 4.5 1.0-11.0 
IQ <50, no syndrome (N = 44) 17.0 0.0-60.0 3.5 1.7-11.0 
IQ < 50, with syndrome (N = 19)† 2.0 0.0-42.0 5.3 3.3-12.0 
Total sample‡ 15.0 0.0-60.0 4.9 1.0-15.0 
Cohort 1 9.0 1.0-60.0 3.9 1.7-11.0 
Cohort 2 18.0 0.0-48.0 5.0 1.0-15.0 
IQ, Intelligence quotient 
*Only children with values for both Age of concern and Age of diagnosis are included (N = 94) 
†All children with genetic syndromes had intelligence quotients of less than 50  
‡The N value varies depending on the variable analyzed, missing from 1 to 4 children 
 
 
 
 
FIGURE 1. Delays between the age of first parental concerns  
and age of autism diagnosis for Cohorts 1 and 2 (N = 94) 
 
 
 
 
 
Children with IQ values of 70 or more were 
significantly older when they received their AD 
diagnoses as compared with children without genetic 
syndromes with IQ values of less than 50 (median, 
3.5 vs. 5.5 years, respectively; z = 2.50; Mann–
Whitney U test, p = .015). Children with genetic 
syndromes were diagnosed with AD at almost the 
same age as children with IQ values of 70 or more 
(median, 5.3 vs. 5.5 years, respectively). 
Figure 1 illustrates the gap between the age of 
parents’ first concerns and the age at AD diagnosis. 
The delay in receiving a diagnosis was greatest for 
children with genetic disorders and for children with 
IQ values in the normal range.  
 
Discussion 
The aim of the present study was fourfold: 1) to 
explore whether two studies conducted 17 years 
apart show a change in the number of children 
diagnosed with AD; 2) to compare child 
characteristics in the two cohorts; 3) to compare 
changes over time in children’s ages at parents’ initial 
concerns and AD diagnosis; and 4) to document the 
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association between child characteristics and age at 
first concern and diagnosis.  
As predicted, we found a significant increase in the 
frequency of diagnosis, from 28 children in 1992 
(about 0.05% of the total child population) to 71 
children in 2009 (about 0.13% of the total child 
population). There were more children with IQ 
values in the average range in the latter cohort. 
Contrary to our expectations, children in Cohort 2 
were somewhat older than those in Cohort 1 both 
when they were suspected of deviant development 
(median, 18 vs. 9 months, respectively) and when 
they received a diagnosis of AD (median, 5.0 vs. 4.5 
years, respectively), although the differences were 
not significant. The proportion of children with 
genetic syndromes remained stable at 21% and 18%, 
respectively. As predicted, parental concerns about 
deviant development emerged earlier for children 
with genetic syndrome, but contrary to predictions, 
these same children were among the oldest to receive 
their AD diagnoses (median, 5.3 years). As predicted, 
the other group that received later AD diagnoses 
(median, 5.5 years) consisted of the more 
intellectually able children (i.e., those with IQ values 
in the average range or higher).  
Awareness of autism has increased among the 
general public as well as among teachers and health 
care personnel. We therefore predicted—in line with 
the findings of Fombonne and colleagues (6)—that 
some of the increase in frequency in Cohort 2 could 
be explained by younger children being diagnosed 
with AD. However, the results of our study indicated 
that there was no significant change in median age at 
diagnosis; in fact, rather than decreasing, the age at 
diagnosis had tended to increase by about 6 months. 
Another expectation was that there would be more 
children with genetic disorders in Cohort 2 due to the 
growing awareness of the increased risk of ASD in 
children with these conditions and the more 
sophisticated techniques used to identify genetic 
disorders. However, the proportion of children with 
such conditions had not changed significantly over 
time. 
The one factor that seems to be associated with the 
change in diagnostic rates is IQ values. The present 
study documents a significant increase (20%) in the 
number of children with IQ values in the normal 
range in Cohort 2. These children tend to show less 
severe autistic symptoms than children with 
additional intellectual disabilities, and they often 
represent more of a diagnostic challenge. The 
increased awareness of AD across the intellectual 
spectrum may have played an important role in 
increasing the rates of AD diagnosis in this particular 
subgroup.  
In both cohorts, the majority of parents suspected 
that there were problems with their children’s 
development before the age of 36 months. The most 
frequent concerns focused on core autism features 
(e.g., social or communication impairments, 
ritualistic behaviors), often in combination with 
language delay or general delay (20,41).There was 
often a substantial delay between the emergence of 
early parental concerns and the diagnosis of AD. 
Moreover, the time gap reported by Crane and 
colleagues (41) did not seem to decrease during the 
past few decades in Nordland County. The failure to 
find a decrease in the average age at diagnosis over 
time was particularly disappointing, especially 
because early diagnosis is important for access to 
appropriate education and intervention. Although 
several studies now suggest a decline in the age at 
diagnosis (18,19), considerable disparities remain. A 
few of these were pointed out in a review by Daniels 
and Mandell (32), which indicated that a general 
increase in awareness does not automatically lead to 
a decrease in diagnostic age (41).  
Delays in obtaining an AD diagnosis were 
particularly marked in children with higher IQ values. 
Their often more subtle aberrances, together with a 
lack of a substantial delay in language development, 
can lead to parents’ early concerns being disregarded 
by professionals, which may result in repeated 
referrals until diagnosis is confirmed (21). This not 
only delays the provision of services, but it also 
negatively affects parental perceptions of the 
diagnostic process and of the clinicians involved and 
increases parental stress (41). These effects were also 
reported in studies by Crane and colleagues (21) and 
Guinchat and colleagues (20).  
By contrast, children with severe cognitive 
impairments (IQ < 50) were more likely to receive an 
early diagnosis. This has also been noted in other 
studies (14,17), and it may be due to the fact that 
young children with delayed developmental 
milestones are more likely to be referred to specialist 
pediatric services with greater expertise in 
recognizing and diagnosing AD at an earlier age. 
Fombonne (6) has argued that data showing an 
increase in AD diagnoses over time are often 
confounded by factors such as referral patterns, the 
availability of services, public awareness, and changes 
in diagnostic concepts and practices. In the present 
study, referral patterns, the availability of services, 
and the service organization in Nordland County had 
changed little over the relevant decades, so these 
factors are less likely to be major contributors to the 
observed increase in the proportion of AD diagnosis. 
Another possible contributing factor is that the 
diagnoses in the two cohorts were based on 
somewhat different diagnostic systems (i.e., the 
DSM-III-R in Cohort 1 and the ICD-10 in Cohort 
2). Volkmar (42) argues that the DSM-III-R seems to 
inflate the number of cases diagnosed as compared 
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with either the ICD-10 or expert clinical judgment. 
The diagnostic criteria for AD (i.e., core autism), 
which is the focus of the present study, have not 
changed greatly over the studied period and have 
tended to remain more stable than the criteria for 
other diagnoses on the spectrum. 
Unfortunately, our data could not be used to 
determine whether diagnostic substitution had 
occurred or to what extent in the two cohorts 
studied. It has been shown by Suren and colleagues 
(43) that, across various counties in Norway, it is 
likely that diagnostic substitution occurs. However, 
in our study, all assessments were done by the same 
hospital in Nordland County and concerned only 
AD, thereby reducing the likelihood of this being a 
key factor in the differences found between the two 
cohorts.  
The other group for whom an AD diagnosis was 
most likely to be delayed was children with genetic 
syndromes. It might be expected that autism in these 
children would be identified early, because they, too, 
are usually involved with specialist pediatric health 
services from an early age (7). Instead, they were 
among the oldest to receive their AD diagnoses. 
Several studies have pointed out that, when autistic 
symptoms are “overshadowed” by genetic 
conditions, the affected children are likely to be 
referred for examination for possible AD much later 
than other children are (7,29,44). This situation may 
prevent them from receiving appropriate 
interventions from an early age. 
To summarize, our findings have indicated a 
significant increase in AD diagnoses in Nordland 
County over a 17-year period, and they corroborate 
the conclusions drawn by studies from other 
countries. Although this was not an epidemiological 
study, the data suggest a rise in prevalence rates; the 
increase cannot be attributed to major changes in 
local referral patterns, clinical diagnostic practices, or 
the availability of services. However, it is possible 
that the rise is influenced by a greater awareness 
among professionals of autism in children of average 
IQ, who were less likely to be recognized in earlier 
years. Unfortunately, any increased awareness of 
autism and AD among relevant professionals in the 
county did not result in a reduction in the age at 
diagnosis, and the gap between parents’ early 
concerns and children’s AD diagnoses did not 
decrease over time. Delays in the age at diagnosis 
were particularly marked in children with IQ values 
in the average range and in those with genetic 
disorders. 
Although the reasons for the increase in the 
number of cases diagnosed over time remain unclear, 
these findings do have important implications for 
diagnosis. 
 
Strengths and limitations of the study 
The main strength of the study is that it includes all 
children diagnosed with AD who were registered 
with the Specialist Health Service in Nordland 
County and residing in the county in 1992 and 2009. 
The children in the two cohorts were born during 
two non-overlapping time periods, and the referral 
patterns and services have not changed.  
Nevertheless, it also suffers from a number of 
methodological problems that limit the conclusions 
that can be drawn. First, the sample size is small. 
Although there was no evidence of substantial 
changes in diagnostic practice over time, 
standardized diagnostic instruments (e.g., the Autism 
Diagnostic Observation Schedule) were used to 
confirm diagnoses in only 14 cases. Second, the study 
compares two clinically referred samples, but 
children with high levels of autistic traits may have 
received educational services without being referred 
to specialized services for a possible diagnosis. Third, 
the use of the DSM-III-R criteria in Cohort 1 and the 
ICD-10 criteria in Cohort 2 may be related to the 
change in diagnostic frequency. However, this would 
be expected to lead to a decrease in diagnostic rates 
(42). Fourth, the results relate only to children 
residing in Nordland County at the two time points 
examined and thus may not be generalizable to other 
counties or other time periods. Finally, the ICD-10 
classification of children into subgroups within the 
autism spectrum can be problematic (45) and can 
lead to misclassification. This might have influenced 
the number of registered children with AD in 
Nordland County. However research has shown 
relatively high agreement for the diagnosis of AD 
specifically (46). 
 
Clinical significance 
In children with genetic syndromes, there seems to 
be a risk of the genetic syndrome “overshadowing” 
the autistic symptom patterns. Results from this 
study show that there is a considerable delay in 
confirming an AD diagnosis in this group, which 
results in the postponing of appropriate intervention 
and support. The potential effects of this delay in 
diagnosis are considerable; they not only affect 
children’s treatment and educational provisions, but 
they may possibly alter long-term outcomes. Crane 
(41) has reported a significant negative impact on 
affected families. Mental health providers should 
ensure that children with genetic syndromes in 
combination with autistic traits are thoroughly 
assessed to clarify whether an AD (or other) 
diagnosis is warranted. If autistic traits are 
consistently described in children with IQ values in 
the normal range, there is a particular need for a 
highly expert diagnostic assessment, because their 
Two Norwegian cohorts of children with autistic disorder 
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symptoms may be subtle or atypical. Greater 
awareness among clinicians of the presentation of 
autism in these groups could have a significant and 
positive impact on the affected children’s age at 
diagnosis and on the provision of appropriate 
interventions and support.  
 
Conflicts of Interest 
The authors declare no conflicts of interest. 
 
 
References 
 
1. Fombonne E. Epidemiology and pervasive developmental 
disorders. In: Perez JM, González PM, Comí ML, Nieto C. (Eds.). 
New developments in autism. The future is today. London: Jessica 
Kingsley; 2007. p. 14-32. 
 
2. Boyle CA, Boulet S, Schieve LA, et al. Trends in the prevalence of 
developmental disabilities in US children, 1997-2008. Pediatrics 
2011;127(6):1034-42. 
 
3. Centers for Disease Control and Prevention (CDC). Prevalence of 
autism spectrum disorder among children aged 8 years - Autism and 
Developmental Disabilities Monitoring Network, 11 sites, United 
States, 2010. MMWR 2014;63(SS#1). 
  
4. Mandell D, Lecavalier L. Should we believe the Centers for Disease 
Control and Prevention's autism spectrum disorder prevalence 
estimates? Autism 2014;18(5):482-4. 
 
5. APA. Diagnostic and Statistical Manual of Mental Disorders DSM-
5. Washingston, DC: American Psychiatric Association; 2013. 
 
6. Fombonne E. Epidemiology of pervasive developmental disorders. 
Pediatr Res 2009;65(6):591-8. 
 
7. Moss J, Howlin P. Autism spectrum disorders in genetic syndromes: 
implications for diagnosis, intervention and understanding the wider 
autism spectrum disorder population. J Intellect Disabil Res 
2009;53(10):852-73. 
 
8. Newschaffer CJ, Croen LA, Daniels J, et al. The epidemiology of 
autism spectrum disorders. Annu Rev Public Health 2007;28:235-
58. 
 
9. DiGuiseppi C, Hepburn S, Davis JM, et al. Screening for autism 
spectrum disorders in children with Down syndrome: population 
prevalence and screening test characteristics. J Dev Behav Pediatr 
2010;31(3):181-91. 
 
10. Moss J, Richards C, Nelson L, Oliver C. Prevalence of autism 
spectrum disorder symptomatology and related behavioural 
characteristics in individuals with Down syndrome. Autism 
2013;17(4):390-404. 
 
11. Warner G, Moss J, Smith P, Howlin P. Autism characteristics and 
behavioural disturbances in ~ 500 children with Down's syndrome 
in England and Wales. Autism Res 2014;7(4):433-41. 
 
12. Berument SK, Rutter M, Lord C, Pickles A, Bailey A. Autism 
Screening Questionnaire: diagnostic validity. Br J Psychiatry 
1999;175:444-51. 
 
13. Wazana A, Bresnahan M, Kline J. The autism epidemic: fact or 
artifact? J Am Acad Child Adolesc Psychiatry 2007;46(6):721-30. 
 
14. Shattuck PT, Durkin M, Maenner M, et al. Timing of identification 
among children with an autism spectrum disorder: findings from a 
population-based surveillance study. J Am Acad Child Adolesc 
Psychiatry 2009;48(5):474-83. 
 
15. Mandell DS, Novak MM, Zubritsky CD. Factors associated with age 
of diagnosis among children with autism spectrum disorders. 
Pediatrics 2005;116(6):1480-6. 
 
16. Coo H, Ouellette-Kuntz H, Lam M, et al. Correlates of age at 
diagnosis of autism spectrum disorders in six Canadian regions. 
Chronic Dis Inj Can 2012;32(2):90-100. 
 
17. Maenner MJ, Schieve LA, Rice CE, et al. Frequency and pattern of 
documented diagnostic features and the age of autism identification. 
J Am Acad Child Adolesc Psychiatry 2013;52(4):401-13 e8. 
 
18. Fountain C, King MD, Bearman PS. Age of diagnosis for autism: 
individual and community factors across 10 birth cohorts. J 
Epidemiol Community Health 2011;65(6):503-10. 
 
19. Hertz-Picciotto I, Delwiche L. The rise in autism and the role of age 
at diagnosis. Epidemiology 2009;20(1):84-90. 
 
20. Guinchat V, Chamak B, Bonniau B, et al. Very early signs of autism 
reported by parents include many concerns not specific to autism 
criteria. Res Autism Spectr Disord 2012;6:589-601. 
 
21. Howlin P, Asgharian A. The diagnosis of autism and Asperger 
syndrome: findings from a survey of 770 families. Dev Med Child 
Neurol 1999;41(12):834-9. 
 
22. Crane L, Maras KL, Hawken T, Mulcahy S, Memon A. Experiences 
of autism spectrum disorder and policing in England and Wales: 
surveying police and the autism community. J Autism Dev Disord 
2016;46(6):2028-41. 
 
23. Howlin P, Moore A. Diagnosis in autism: a survey of over 1200 
parents. Autism 1997;1(2):135-62. 
 
24. Kim YS, Leventhal BL, Koh YJ, et al. Prevalence of autism spectrum 
disorders in a total population sample. Am J Psychiatry 
2011;168(9):904-12. 
 
25. Isaksen J, Diseth TH, Schjolberg S, Skjeldal OH. Observed 
prevalence of autism spectrum disorders in two Norwegian counties. 
Eur J Paediatr Neurol 2012;16(6):592-8. 
 
26. Bishop DV, Whitehouse AJ, Watt HJ, Line EA. Autism and 
diagnostic substitution: evidence from a study of adults with a 
history of developmental language disorder. Dev Med Child Neurol 
2008;50(5):341-5. 
 
27. Shattuck PT. Diagnostic substitution and changing autism 
prevalence. Pediatrics 2006;117(4):1438-9. 
 
28. Miodovnik A, Harstad E, Sideridis G, Huntington N. Timing of the 
diagnosis of attention-deficit/hyperactivity disorder and autism 
spectrum disorder. Pediatrics 2015;136(4):e830-7. 
 
29. Dykens EM. Psychiatric and behavioral disorders in persons with 
Down syndrome. Ment Retard Dev Disabil Res Rev 2007;13(3):272-
8. 
 
30. APA. Diagnostic and Statistical Manual of Mental Disorders DSM-
IV. Washington, DC: American Psychiatric Association; 2000. 
 
31. WHO. International Statistical Classification of Diseases and 
Related Health Problems. Geneva: World Health Organisation; 
1992. 
 
32. Daniels AM, Mandell DS. Explaining differences in age at autism 
spectrum disorder diagnosis: a critical review. Autism 
2014;18(5):583-97. 
 
33. Lord C. Early assessment of autistic spectrum disorders. In: Perez 
JM, González PM, Comí ML, Nieto C. (Eds.). New developments 
in autism. The future is today. London: Jessica Kingsley; 2007. p. 58-
75. 
 
34. Herder GA. [Infantile autism among children in the county of 
Nordland. Prevalence and etiology]. Tidsskr Nor Laegeforen 
1993;113(18):2247-9. 
Two Norwegian cohorts of children with autistic disorder 
 
 
12 
 
 
35. APA. Diagnostic and Statistical Manual of Mental Disorders DSM-
III-R. Washington, DC: American Psychiatric Association; 1987. 
 
36. Lord C, Risi S, Lambrecht L, Cook EH, Jr., et al. The Autism 
Diagnostic Observation Schedule-Generic: a standard measure of 
social and communication deficits associated with the spectrum of 
autism. J Autism Dev Disord 2000;30(3):205-23. 
 
37. Sparrow S, Balla DA, Cicchetti DV, Doll EA. Vineland Adaptive 
Behavior Scales: Interview Edition. Circla Pines, MN: American 
Guidance Service; 1984. 
 
38. Bayley N. Bayley Scales of Infant and Toddler Development, third 
edition. San Antonio, TX: Pearson Psychological Corporation; 2006. 
 
39. SPSS Statistics for Windows, v23. Version 23.0. ed. Armonk, NY: 
IBM Corp.; 2014. 
 
40. Massey FJ. The Kolmogorov-Smirnov Test for Goodness of Fit. J 
Am Stat Assoc 1951;46(253):68-78. 
 
41. Crane L, Chester JW, Goddard L, Henry LA, Hill E. Experiences of 
autism diagnosis: a survey of over 1000 parents in the United 
Kingdom. Autism 2016;20(2):153-62. 
 
42. Volkmar FR, Cicchetti DV, Bregman J, Cohen DJ. Three diagnostic 
systems for autism: DSM-III, DSM-III-R, and ICD-10. J Autism 
Dev Disord 1992;22(4):483-92. 
 
43. Suren P, Bakken IJ, Lie KK, et al. Differences across counties in the 
registered prevalence of autism, ADHD, epilepsy and cerebral palsy 
in Norway. Tidsskr Nor Laegeforen 2013;133(18):1929-34. 
 
44. Gillberg C, Coleman M. Autism and medical disorders: a review of 
the literature. Dev Med Child Neurol 1996;38(3):191-202. 
 
45. Willemsen-Swinkels SH, Buitelaar JK. The autistic spectrum: 
subgroups, boundaries, and treatment. Psychiatr Clin North Am 
2002;25(4):811-36. 
 
46. Volkmar FR, Klin A, Siegel B, et al. Field trial for autistic disorder 
in DSM-IV. Am J Psychiatry 1994;151(9):1361-7. 
 
 
